Brain cancer module: QLQ-BN Scope. The brain cancer module is meant for use among brain cancer patients varying in disease stage and treatment. The EORTC QLQ-BN20 questionnaire for assessing the health-related quality of life (HRQoL) in brain cancer patients: A phase IV validation. To be used in conjunction with the EORTC QLQ-C30 for measuring the health- related quality of life in patients with brain cancer.
|Published (Last):||8 August 2009|
|PDF File Size:||20.20 Mb|
|ePub File Size:||10.74 Mb|
|Price:||Free* [*Free Regsitration Required]|
The estimates generally agree with the estimates of 5—10 units of the QLQ-C30 scales we considered and as proposed by Osoba et al. None, Conflict of Interest: These anchors are clearly definable, understandable, and are commonly used by clinicians in assessment of cancer patients and could therefore help guide interpretation of HRQoL scores.
Is a patient’s self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients?
Quality of life of breast cancer patients in Taiwan: Another look at the half standard deviation estimate of the minimally important difference in health-related quality of life scores. Interpreting the significance of changes in health related quality-of-life scores. The Mini-Mental State Examination in general medical practice: Therefore, to control for the amount of change in HRQoL that occurred to patients who did not change according to the anchor, we obtained estimates of the MCID by calculating the difference in mean HRQoL change between adjacent categories [ 11 ], i.
Measurement of health status: Meaningful change in cancer-specific quality of life scores: Of the 30 items, 24 aggregate into nine multi-item scales representing various HRQoL dimensions: Online since 1 st AprilNew website online since 6 th Aug Distribution-based approaches hinge on the statistical features of the HRQoL data. Since the results for T 1 and T 2 were very similar, only the results at T 1 are reported.
However, the evidence is not clear that a point threshold is applicable to each of the 15 QLQ-C30 scales [ 15 ]. Identification of MCIDs was carried out using two clinical anchors: A threshold of 0. Determining clinically important differences in health status measures: Q qpq-bn20 and Q 3 are the lower and upper quartiles.
Sign In or Create an Account. Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapy. Prosthetics and Orthotics International.
EORTC Quality of Life Questionnaire – Brain Cancer Module (EORTC QLQ-BN20)
Excluded from the PS analyses erotc two patients whose PS deteriorated eogtc two categories and 51 patients whose PS improved by two or more categories. Note that patients could be categorized differently between the anchor and HRQoL measures, e.
Q,q-bn20 percent confidence intervals CI for the differences in mean of change scores between adjacent categories the MCID were calculated. Changes in MMSE were eorrtc as: Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: Had we used a one-category change in the point Karnofsky performance scale, our results would probably differ.
This paper has been referenced on Twitter 1 time over the past 90 days. Descriptive statistics summarizing the distributions of HRQoL scores at baseline are given in Table 2. Citing articles via Web of Science It will take a large number of such explorations to increase the confidence and familiarity of investigators. The remaining six single-item scales assess symptoms: In general, the mean changes in HRQoL within each anchor-defined category were in the expected direction.
P values, does not provide information about the clinical meaningfulness.
Furthermore, it has not yet been established whether the same thresholds apply to improvement and deterioration in HRQoL scores.
Close mobile search navigation Article navigation.
EORTC QLQ-BN20 – EORTC Quality of Life Questionnaire – Brain Cancer Module
The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. For illustration, the first difference in PF mean change of adjacent categories is obtained as 4. Analysis of health-related quality of life in patients with brain tumors prior and subsequent to radiotherapy. This provides further evidence that the 0.
This article has been cited by 1 Prospective assessment of quality of life in adult patients with primary brain tumors in routine neurooncology practice Budrukkar, A.